Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Continues Its Introduction of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, During American Academy of Ophthalmology (AAO) 2024
Nordic Pharma to share this innovation and its pivotal study article in the Journal of Cataract and Refractive Surgery (JCRS) with ophthalmology leaders BERWYN, Pa.–(BUSINESS...